Invivyd, Inc. SEC filings IVVD
Invivyd, Inc. has 448 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| 3 | Initial insider ownership | Sep 2, 2026 | Aug 30, 2026 |
| 4 | Insider transaction | Sep 1, 2026 | Aug 30, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 1, 2026 | Aug 30, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 15, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Jul 31, 2026 |
| 3 | Initial insider ownership | Aug 4, 2026 | Jul 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 28, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jul 24, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Other events
|
Jul 6, 2026 | Jul 6, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2026 | May 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| S-8 | Employee stock plan registration | May 14, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 9, 2026 | Apr 9, 2026 |
| ARS | Annual report to shareholders | Apr 6, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 6, 2026 | — |
| DEF 14A | Proxy statement | Apr 6, 2026 | May 19, 2026 |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 5, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 15, 2026 |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 4 | Insider transaction | Jan 30, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 29, 2026 |
| 4 | Insider transaction | Jan 30, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 29, 2025 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| 144 | Notice of proposed sale | Dec 23, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 23, 2025 | Dec 23, 2025 |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| S-3/A | Filing | Dec 19, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 25, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 19, 2025 | Nov 17, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 19, 2025 | — |
| 424B5 | Prospectus supplement | Nov 19, 2025 | — |
| FWP | Free writing prospectus | Nov 17, 2025 | — |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| 424B5 | Prospectus supplement | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 12, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Oct 30, 2025 | Oct 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 14, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 6, 2025 | Oct 6, 2025 |
| S-3 | Shelf registration | Oct 2, 2025 | — |
| 4 | Insider transaction | Sep 24, 2025 | Sep 22, 2025 |
| 3 | Initial insider ownership | Sep 24, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 24, 2025 | Sep 22, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 29, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 27, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 26, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Aug 22, 2025 | Aug 20, 2025 |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| FWP | Free writing prospectus | Aug 20, 2025 | — |
| 424B5 | Prospectus supplement | Aug 20, 2025 | — |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 144 | Notice of proposed sale | Aug 18, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2025 | Aug 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 2, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Other events
|
Jun 26, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2025 | May 20, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Other events
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2025 | Apr 21, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Apr 21, 2025 | Apr 18, 2025 |
| ARS | Annual report to shareholders | Apr 7, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 7, 2025 | — |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 20, 2025 |
| 4 | Insider transaction | Mar 26, 2025 | Mar 24, 2025 |
| 3 | Initial insider ownership | Mar 26, 2025 | Mar 22, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 26, 2025 | Mar 22, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Other events
|
Feb 24, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 15, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 15, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 15, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 15, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Results of operations, Other events
|
Feb 3, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Other events
|
Jan 27, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Dec 31, 2024 | Dec 27, 2024 |
| 8-K |
Current report
Listing notice
|
Dec 27, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| 144 | Notice of proposed sale | Dec 20, 2024 | — |
| 4 | Insider transaction | Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 12, 2024 | — |
| 4 | Insider transaction | Dec 11, 2024 | Dec 9, 2024 |
| 144 | Notice of proposed sale | Dec 9, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 2, 2024 | Nov 27, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Other events
|
Sep 23, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Sep 6, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Other events
|
Sep 4, 2024 | Sep 4, 2024 |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Other events
|
Aug 27, 2024 | Aug 27, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 3 | Initial insider ownership | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
May 31, 2024 | May 30, 2024 |
| 144 | Notice of proposed sale | May 29, 2024 | — |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 3 | Initial insider ownership | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 3 | Initial insider ownership | May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
May 22, 2024 | May 21, 2024 |
| 144 | Notice of proposed sale | May 16, 2024 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Other events
|
May 7, 2024 | May 7, 2024 |
| EFFECT | Filing | Apr 19, 2024 | — |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| CORRESP | Letter to the SEC | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | May 21, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 12, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Other events
|
Apr 4, 2024 | Apr 4, 2024 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IVVD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1832038
- Former names
- Adagio Therapeutics, Inc. (until Sep 12, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.